Figure 1From: Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience HOMA- IR as indicator of insulin resistance in pre and post-menopausal patients with breast cancer. Back to article page